TaiRx, Inc. (TPEX:6580)
Taiwan · Delayed Price · Currency is TWD 21.50
+0.05 (0.23%)
Jan 21, 2026, 1:59 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 2.37 billion as of January 21, 2026. Its market cap has decreased by -21.10% in one year.
Market Cap
2.37B
Enterprise Value
1.95B
Revenue
15.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.50
Market Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 2.37B, a decrease of -27.13%. That is a compound annual growth rate of -3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.37B | -2.28% |
| Dec 31, 2025 | 2.42B | -15.03% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Lin BioScience | 31.15B |